Stephen J Tulipano Insider Trading
Get free email notifications about insider trading for Stephen J Tulipano.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stephen J Tulipano. Stephen J Tulipano is a CFO and Secretary in JAVELIN PHARMACEUTICALS, INC ($ITRD) and a Chief Financial Officer in JAVELIN PHARMACEUTICALS, INC ($ITRD) and a Chief Financial Officer in Aldeyra Therapeutics, Inc. ($ALDX) and a CFO in Stoke Therapeutics, Inc. ($STOK).
Address: C/O JAVELIN PHARMACEUTICALS, INC. 125 CAMBRIDGEPARK DRIVE CAMBRIDGE 02140 MA
Companies in which Stephen J Tulipano is an Insider
Aldeyra Therapeutics, Inc.
Trading Symbol: ALDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen J Tulipano: Chief Financial Officer
Holdings: 5,410 shares
Current Value: $27,050
Latest Transaction: Mar 08 2018
$ALDX Market Capitalization: $30.29M
$ALDX Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
JAVELIN PHARMACEUTICALS, INC
Trading Symbol: ITRDIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen J Tulipano: CFO and Secretary, Chief Financial Officer
Holdings: 22,615 shares
Latest Transaction: May 05 2010
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Stoke Therapeutics, Inc.
Trading Symbol: STOKIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stephen J Tulipano: CFO
Holdings: 25,602 shares
Latest Transaction: Mar 04 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Stephen J Tulipano
Sentiment: All, ALDX, ITRD, STOK
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 04 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | A | 60.00 | 65,600 | 3,936,000 | 65,600 | |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 5,000 | 22,400 | 179,997 | |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Option Exercise | M | 4.48 | 25,000 | 112,000 | 184,997 | |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 58.60 | 5,000 | 292,992 | 602 | 5.6 K to 602 (-89.25 %) |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Buy | M | 4.48 | 5,000 | 22,400 | 5,602 | 602 to 5.6 K (+830.56 %) |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 60.00 | 102 | 6,120 | 602 | 704 to 602 (-14.49 %) |
Feb 24 2021 | STOK | Stoke Therapeutics ... | Tulipano Stephen J | CFO | Sell | S | 59.29 | 9,696 | 574,842 | 704 | 10.4 K to 704 (-93.23 %) |